Although the effect of β-catenin inhibition on suppressing lung metastasis in VE-Cad-CreAkt1 mice would appear to be a promising strategy to prevent prostate cancer metastasis, our experience with regard to the role of Akt1 in advanced prostate cancer informs us to be more cautious with such an approach. This evidence concerns the gene AKT1 and prostate carcinoma.